Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-03-21Clinical Trial Update: Efficacy of a Coaching Program to Promote Physical Activity and Reduce Sedentary Behavior After a COPD Hospitalization [NA]
This clinical trial update investigates whether a coaching program can increase physical activity and reduce sedentary time after hospitaliz…
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices [Phase 4]
Phase 4 clinical trial update evaluating inhaler device attributes, including critical and total error rates, ease of use, and user preferen…
-
CLINICAL_TRIALS research · 2017-03-16Clinical Trial Update: The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy [NA]
A clinical trial evaluating the efficacy of the AIRVO Warm Humidifier as an add-on to oxygen therapy in patients with Chronic Obstructive Pu…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Effect of Supplemental Oxygen on Maximal Oxygen Consumption in Patients With Chronic Obstructive Pulmonary Disease [NA]
This clinical trial update reports on the effect of supplemental oxygen on maximal oxygen consumption in patients with chronic obstructive p…
-
CLINICAL_TRIALS withdrawal · 2017-03-16Clinical Trial Update: Adipose Derived Cells for Chronic Obstructive Pulmonary Disease [NA]
A clinical trial evaluating adipose-derived cells for chronic obstructive pulmonary disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD [Phase 3]
A Phase 3 trial evaluated tolerability and pharmacokinetics of roflumilast at 250 μg and 500 μg as add-on therapy to standard COPD treatment…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Effects of Inspiratory Muscle Training in COPD [Phase 3]
A Phase 3 trial evaluating inspiratory muscle training for chronic obstructive pulmonary disease and inspiratory muscle weakness has complet…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Staccato Loxapine Pulmonary Safety in Patients With COPD [Phase 1]
Phase 1 trial update assessing the pulmonary safety of inhaled loxapine (Staccato) in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Telemonitoring in Pulmonary Rehabilitation: Validity of a Remote Pulse Oxymetry System
This clinical trial update reports on the validity of a remote pulse oximetry telemonitoring system for patients with chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Use of Internet Mediated Walking Program and Pedometer in COPD [NA]
A completed clinical trial from VA Boston Healthcare System evaluating an internet-mediated walking program with a pedometer for chronic obs…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 clinical trial update for TD-4208 in COPD subjects; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 trial evaluating GSK2269557 added to standard care in acute exacerbation of chronic obstructive pulmonary disease has completed with…
-
CLINICAL_TRIALS research · 2017-03-09Clinical Trial Update: Quality of Life in Pulmonary Rehabilitation: A Social Identity Based Intervention [NA]
This completed clinical trial evaluated a social identity-based intervention to improve quality of life for people with chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 randomized trial comparing Fluticasone furoate/vilanterol to standard COPD therapy has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD [NA]
A completed clinical trial evaluating immune responses to specific microbial antigens in healthy smokers, healthy non-smokers, and individua…
-
CLINICAL_TRIALS research · 2017-03-06Clinical Trial Update: Magnesium is Associated With QoL in COPD: A Cross-sectional Study
A cross-sectional study from the University of Aarhus reports an association between magnesium status and quality of life in people with chr…
-
CLINICAL_TRIALS research · 2017-03-06Clinical Trial Update: Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
This document provides an update on a clinical trial evaluating home monitoring of chronic obstructive pulmonary disease patients using a fo…
-
CLINICAL_TRIALS research · 2017-03-06Clinical Trial Update: Nasal, Tracheal and Bronchial Mucosal Lining Fluid(MLF) Sampling From Patients With Respiratory Diseases
This clinical trial update describes sampling of nasal, tracheal, and bronchial mucosal lining fluid from patients with various respiratory …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Effects of Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease (COPD) [NA]
This update reports the completion of a trial evaluating inspiratory muscle training for patients with COPD, including those with inspirator…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial evaluating inhaled human insulin in people with diabetes mellitus and chronic obstructive pulmonary disease has been terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Well Being and Rehabilitation in Chronically Ill Patients: Structured Patient Education and Physical Exercise [NA]
A completed clinical trial evaluating structured patient education and physical exercise for well-being and rehabilitation in chronically il…
-
FDA approval · 2017-02-28FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
FDA granted a supplemental approval for Advair Diskus (fluticasone propionate and salmeterol) by GlaxoSmithKline LLC.
-
FDA approval · 2017-02-28FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for ADVAIR HFA (fluticasone propionate and salmeterol xinafoate) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 BEAM COPD study (Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease) has completed its Phase 2 tr…
-
FDA approval · 2017-02-27FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate).